The first stop for professional medicines advice

Intrathecal medicines

29 results

RelevanceNewest firstOldest firstTitle
Applied filters

Morphine: informing intrathecal risk assessment

11 August 2022Morphine sulfate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Methotrexate: informing intrathecal risk assessment

11 August 2022Methotrexate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Lidocaine: informing intrathecal risk assessment

11 August 2022Lidocaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Levobupivacaine: informing intrathecal risk assessment

11 August 2022Levobupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Intrathecal administration

Understand what to consider when giving medicines via the intrathecal route and use our material to help inform your risk assessment

Hydromorphone: informing intrathecal risk assessment

11 August 2022Hydromorphone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Hydrocortisone: informing intrathecal risk assessment

11 August 2022Hydrocortisone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Hydrocortisone acetate: informing intrathecal risk assessment

11 August 2022Hydrocortisone acetate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Gentamicin: informing intrathecal risk assessment

11 August 2022Gentamicin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Fluorescein: informing intrathecal risk assessment

11 August 2022Fluorescein products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration